New Mississippi Medical Device Establishment License

Sandy Carter

Senior Manager, Research and Development

The Mississippi Board of Pharmacy (MS BOP) has introduced a new Medical Device Establishment license. Creating additional regulatory requirements for businesses involved in the manufacturing or distribution of certain medical devices in the state.

This change stems from a revision to the state’s statutory definition of a “device,” which expands regulatory oversight for prescription devices intended for professional use.

Definition of a Medical Device in the State of Mississippi

The primary regulatory shift comes from a change in how Mississippi defines a medical device.

The previous definition: “Device” means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent or other similar or related article, including any component part or accessory which is required under federal or state law to be prescribed by a practitioner and dispensed by a pharmacist.

The new definition: (g) "Device" means an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent or other similar or related article, including any component part or accessory which is required under federal or state law to be prescribed by a practitioner.

By removing the requirement that the device be dispensed by a pharmacist, the definition now captures prescription devices intended for professional use, bringing them under state regulatory oversight.

This interpretation has been confirmed with the Mississippi Board of Pharmacy.

Who is Affected by The Mississippi Device Requirement Change?

This will affect a number of businesses operating within the state, including:

Manufacturers
Wholesalers
Virtual Manufacturers
Virtual Wholesalers
Third-party logistics providers
Repackagers
Relabelers

Impact on Third-Party Logistics Providers (3PLs)

The regulatory changes also affect third-party logistics providers:

3PLs are not generally required to obtain a Medical Device Establishment license.
However, 3PLs that were previously exempt because they only handled prescription devices for professional use must now obtain a Mississippi 3PL license.
This means companies that previously operated without licensure due to the narrow device definition may now need to become licensed.

When Multiple Licenses Are Not Required

Facilities that handle both prescription drugs and prescription devices will not need to obtain an additional device license.

Existing Manufacturer or Wholesale Distributor licenses will cover both prescription drugs and prescription devices as well.

Fees and Compliance Timeline

The new licensing structure includes the following requirements:

License fee: $500
Initial licensure deadline: July 1, 2026
Initial license expiration: December 31, 2027
All future regulatory assessments will reflect this new requirement.

Next Steps for Industry

Companies that previously operated under exemptions, particularly those that handled prescription devices for professional use, should review their operations to determine whether they must now obtain licensure.

Specifically:

3PLs that previously handled only professional-use prescription devices will now need a Mississippi 3PL license.
Manufacturers, Wholesalers, Virtual Manufacturers, Virtual Wholesalers, Repackagers, and Relabelers handling only medical devices will need to obtain a Medical Device Establishment license.
Organizations should begin evaluating their licensing status and contacting affected clients to ensure compliance ahead of the July 1, 2026 deadline.

Sources

Mississippi January 2026 The Script Quarterly Newsletter: https://www.mbp.ms.gov/sites/default/files/inline-images/January%20Newsletter%202026_1.pdf

LighthouseAI Regulatory Monitoring

If you didn't already know about this new Mississippi requirement, you're not alone.

However, missing requirements like this can mean fines, suspended shipments, or disciplinary actions.

LighthouseAI monitors all US states and sends automated alerts tailored to your product portfolio and facility operations. No noise. No manual research. Just the updates that matter to you, with enough time to act.

What you don't know can hurt you. LighthouseAI will make sure you know.

Questions

If you have any questions about this latest licensing regulatory requirement, please contact us at hello@lighthouseai.com.

About the Author:

Sandy Cater is a Senior Manager of Research and Development at LighthouseAI with over a decade of experience in the pharmaceutical life sciences industry. She specializes in regulatory compliance research and analysis across the pharmaceutical sector. Sandy focuses on developing high-quality compliance insights and research methodologies that help organizations navigate complex regulatory frameworks and maintain compliance throughout the pharmaceutical supply chain.